Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) is now available.
Charmacy Pharmaceutical Co., Ltd. held an Extraordinary General Meeting on December 12, 2025, where all proposed resolutions were approved by shareholders. Key decisions included the approval of a new framework loan agreement with Jiangyao Group Co., Ltd., the appointment of Pan-China Certified Public Accountants LLP as the company’s auditors, and the abolishment of the Board of Supervisors. These changes are expected to streamline the company’s governance structure and potentially enhance its financial operations.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the distribution and sale of pharmaceutical products.
Average Trading Volume: 2,818
Technical Sentiment Signal: Sell
Current Market Cap: HK$670.7M
See more insights into 2289 stock on TipRanks’ Stock Analysis page.